© 1991 Oxford University Press
research-article |
Transfection and expression of human O6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents
Department of Genetics and Toxicology, Nuclear Research Center Karlsruhe Postfach 3640, D-7500 Karlsruhe 1, FRG USA
1Biology Division, Oak Ridge National Laboratoiy Oak Ridge, TN 37831, USA
O6-Methylguanine-DNA methyltransferase (MGMT) is responsible for removal of O6-alkylguanine from DNA induced by alkylating mutagens/carcinogens. To analyze the involvement of O6-alkylguanine in the generation and MGMT in avoidance of various genotoxic effects of alkylating agents, we transfected Chinese hamster ovary (CHO) cells that lack MGMT activity with human MGMT cDNA cloned into a mammalian expression vector (pSV2MGMI). A high proportion (60–80%) of transfectants selected for a cotransfected neo gene survived treatment with high doses of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and N-hydroxyethyl-N-chloroethylnitrosourea (HeCNU). Parallel transfections with an expression vector containing the bacterial ada gene (pSV2ada) showed the human MGMT to be more effective than the ada expression vector in mediating alkylation resistance. Various clonal CHO cell lines have been established stably transfected with the human MGMT cDNA. The transfectants expressed human MGMT at levels ranging from 8600 to 210 000 molecules per cell. The high MGMT expressors became strongly resistant to the killing effects of MNNG, HeCNU, N-methyl-N-nitrosourea (MNU) and, to a significant lesser degree, methyl methanesulfonate (MMS) and ethyl methanesulfonate (EMS). No killing resistance was observed to N-ethyl-N-nitrosourea (ENU), though the MGMT and ada transfectants showed reduction in mutation frequency induced by this agent. Protection from mutation induction by MGMT (and ada) expression was also demonstrated for MNNG. The transfectants were also protected from the sister chromatid exchange (SCE) inducing and, to a lesser degree, clastogenic effect of MNNG and MNU, and slightly to EMS and MMS. Again no protection was observed towards ENU. Correlations between MGMT activity and resistance to a given end point suggest that, for MINNG, O6 is the preponderant toxic, mutagenic and SCE inducing lesion. About 90% of MNNG (and MNU) induced SCEs and nearly all of the MNNG-induced gene mutations seem to be due to this adduct. For alkylation-induced chromosomal aberrations, however, and for cell killing and SCEs induced by MMS EMS and ENU, other lesions than O6-alkylguanine appear to be of major Importance. The data strongly support the view that O6-methylguanine is a genotoxic lesion and MGMT a function decisively involved in avoidance of genotoxic effects in cells exposed to MNNG and related compounds. They
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. E. Hegi, L. Liu, J. G. Herman, R. Stupp, W. Wick, M. Weller, M. P. Mehta, and M. R. Gilbert Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity J. Clin. Oncol., September 1, 2008; 26(25): 4189 - 4199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F.Z. Batista, W. P. Roos, M. Christmann, C. F.M. Menck, and B. Kaina Differential Sensitivity of Malignant Glioma Cells to Methylating and Chloroethylating Anticancer Drugs: p53 Determines the Switch by Regulating xpc, ddb2, and DNA Double-Strand Breaks Cancer Res., December 15, 2007; 67(24): 11886 - 11895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sanada, M. Hidaka, Y. Takagi, T. Y. Takano, Y. Nakatsu, T. Tsuzuki, and M. Sekiguchi Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosis Carcinogenesis, December 1, 2007; 28(12): 2657 - 2663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lundin, M. North, K. Erixon, K. Walters, D. Jenssen, A. S. H. Goldman, and T. Helleday Methyl methanesulfonate (MMS) produces heat-labile DNA damage but no detectable in vivo DNA double-strand breaks Nucleic Acids Res., July 11, 2005; 33(12): 3799 - 3811. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kaina, U. Muhlhausen, A. Piee-Staffa, M. Christmann, R. Garcia Boy, F. Rosch, and R. Schirrmacher Inhibition of O6-Methylguanine-DNA Methyltransferase by Glucose-Conjugated Inhibitors: Comparison with Nonconjugated Inhibitors and Effect on Fotemustine and Temozolomide-Induced Cell Death J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 585 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Claij, A. van der Wal, M. Dekker, L. Jansen, and H. te Riele DNA Mismatch Repair Deficiency Stimulates N-Ethyl-N-nitrosourea-induced Mutagenesis and Lymphomagenesis Cancer Res., May 1, 2003; 63(9): 2062 - 2066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Becker, C. Gregel, C. Fricke, D. Komitowski, J. Dosch, and B. Kaina DNA repair protein MGMT protects against N-methyl-N-nitrosourea-induced conversion of benign into malignant tumors Carcinogenesis, March 1, 2003; 24(3): 541 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ochs, J. Lips, S. Profittlich, and B. Kaina Deficiency in DNA Polymerase {beta} Provokes Replication-dependent Apoptosis via DNA Breakage, Bcl-2 Decline and Caspase-3/9 Activation Cancer Res., March 1, 2002; 62(5): 1524 - 1530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ochs and B. Kaina Apoptosis Induced by DNA Damage O -Methylguanine Is Bcl-2 and Caspase-9/3 Regulated and Fas/Caspase-8 Independent Cancer Res., October 1, 2000; 60(20): 5815 - 5824. [Abstract] [Full Text]
|
|
|
|
|
|
C. L. Nutt, M. Noble, A. F. Chambers, and J. G. Cairncross Differential Expression of Drug Resistance Genes and Chemosensitivity in Glial Cell Lineages Correlate with Differential Response of Oligodendrogliomas and Astrocytomas to Chemotherapy Cancer Res., September 1, 2000; 60(17): 4812 - 4818. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Parra, F. Lluis, F. Miralles, C. Caelles, and P. Munoz-Canoves The cJun N-terminal kinase (JNK) signaling pathway mediates induction of urokinase-type plasminogen activator (uPA) by the alkylating agent MNNG Blood, August 15, 2000; 96(4): 1415 - 1424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Nutt, N. A. Loktionova, A. E. Pegg, A. F. Chambers, and J.g. Cairncross O6-Methylguanine-DNA methyltransferase activity, p53 gene status and BCNU resistance in mouse astrocytes Carcinogenesis, December 1, 1999; 20(12): 2361 - 2365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Glassner, G. Weeda, J. M. Allan, J. L.M. Broekhof, N. H.E. Carls, I. Donker, B. P. Engelward, R. J. Hampson, R. Hersmus, M. J. Hickman, et al. DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents Mutagenesis, May 1, 1999; 14(3): 339 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ochs, R. W. Sobol, S. H. Wilson, and B. Kaina Cells Deficient in DNA Polymerase {beta} Are Hypersensitive to Alkylating Agent-induced Apoptosis and Chromosomal Breakage Cancer Res., April 1, 1999; 59(7): 1544 - 1551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Humbert, S. Fiumicino, G. Aquilina, P. Branch, S. Oda, A. Zijno, P. Karran, and M. Bignami Mismatch repair and differential sensitivity of mouse and human cells to methylating agents Carcinogenesis, February 1, 1999; 20(2): 205 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. Engelward, J. M. Allan, A. J. Dreslin, J. D. Kelly, M. M. Wu, B. Gold, and L. D. Samson A Chemical and Genetic Approach Together Define the Biological Consequences of 3-Methyladenine Lesions in the Mammalian Genome J. Biol. Chem., February 27, 1998; 273(9): 5412 - 5418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Dumenco, E Allay, K Norton, and S. Gerson The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase Science, January 8, 1993; 259(5092): 219 - 222. [Abstract] [PDF]
|
|
|
|
|
|
M. Christmann and B. Kaina Nuclear Translocation of Mismatch Repair Proteins MSH2 and MSH6 as a Response of Cells to Alkylating Agents J. Biol. Chem., November 10, 2000; 275(46): 36256 - 36262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Parra, M. Jardi, M. Koziczak, Y. Nagamine, and P. Munoz-Canoves p53 Phosphorylation at Serine 15 Is Required for Transcriptional Induction of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene by the Alkylating Agent N-Methyl-N'-nitro-N-nitrosoguanidine J. Biol. Chem., September 21, 2001; 276(39): 36303 - 36310. [Abstract] [Full Text] [PDF]
|
|